文献速递主动脉疾病

拟行腹主动脉瘤腔内修复术患者同期经皮冠状动脉介入治疗的快速通道管理

Fast-Track Management of Concurrent Percutaneous Coronary Intervention in Patients Scheduled for Endovascular Abdominal Aortic Aneurysm Repair.
PubMed 文献 · J Endovasc Ther · 2022-07-04

这项回顾性队列研究纳入2011年1月至2019年12月接受腹主动脉瘤腔内修复术(EVAR)的669例患者(快速通道组73例,标准对照组596例),采用倾向性评分匹配分析比较快速通道管理与标准对照的短期和中期结局。快速通道组与标准对照组在主要不良心脏事件、总死亡率和30天重大出血事件上均无显著差异,倾向性评分匹配队列结果一致。作者认为在适当围术期管理下,将经皮冠状动脉介入治疗(PCI)与EVAR间隔缩短至1个月甚至2周似乎是安全有效的。

要点

  • 快速通道组与标准对照组的主要不良心脏事件无显著差异(HR 0.78,95%CI 0.36-1.68,p=0.519)。
  • 两组总死亡率无显著差异(HR 0.63,95%CI 0.25-1.55,p=0.315)。
  • 作者认为PCI与EVAR间隔缩短至1个月甚至2周似乎是安全有效的。

核心结论

  • 在适当围术期管理下,将PCI与EVAR之间的时间间隔缩短至1个月甚至2周似乎是安全有效的。
  • 快速通道管理患者的短期和中期心血管及生存结局与未合并显著冠状动脉疾病而接受标准EVAR的患者相当。

研究设计与样本

  • 回顾性队列研究,纳入2011年1月至2019年12月接受EVAR的腹主动脉瘤患者。
  • 共纳入669例患者,其中快速通道组73例,标准对照组596例。
  • 采用倾向性评分匹配分析平衡快速通道组与标准对照组的基线特征。
  • 通过Cox比例风险回归和logistic回归分析评估快速通道管理对短期和中期结局的影响,并报告相应的风险比(HR)或比值比(OR)及95%置信区间(95%CI)。

主要发现

  • 与标准对照组相比,快速通道组主要不良心脏事件无显著差异(HR 0.78,95%CI 0.36-1.68,p=0.519)。
  • 与标准对照组相比,快速通道组总死亡率无显著差异(HR 0.63,95%CI 0.25-1.55,p=0.315)。
  • 与标准对照组相比,快速通道组30天重大出血事件无显著差异(OR 1.01,95%CI 0.99-1.03,p=0.514)。
  • 在倾向性评分匹配队列中,主要不良心脏事件无显著差异(HR 0.57,95%CI 0.25-1.29,p=0.176)。
  • 在倾向性评分匹配队列中,总死亡率无显著差异(HR 0.43,95%CI 0.17-1.11,p=0.820),30天重大出血事件无显著差异(OR 1.00,95%CI 0.05-10.61,p=0.999)。

临床怎么用

  • 作者认为,在适当围术期管理下,将PCI与EVAR的时间间隔缩短至1个月甚至2周似乎是安全有效的。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the safety and efficacy of fast-track management of concurrent percutaneous coronary intervention (PCI) in patients with abdominal aortic aneurysm scheduled for endovascular aortic aneurysm repair (EVAR). MATERIALS AND METHODS: Eligible patients with abdominal aortic aneurysm who received EVAR from January 2011 to December 2019 were included in this retrospective cohort study. Propensity score (PS)-matched analysis was used to balance the baseline between the fast-track and standard control (EVAR without significant coronary artery disease) groups. Effects of fast-track management on short-term and midterm outcomes were evaluated via Cox proportional hazard regression and logistic regression analyses with corresponding hazard ratio (HR) or odds ratio (OR) and associated 95% confidence intervals (95% CIs), respectively. RESULTS: The study included 669 patients (73 fast-track and 596 standard control). Compared with the standard control group, no significant difference was found regarding major adverse cardiac events (HR 0.78, 95% CI [0.36, 1.68], p=0.519), overall mortality (HR 0.63, 95% CI [0.25, 1.55], p=0.315), and 30-day major hemorrhage events (OR 1.01, 95% CI [0.99, 1.03], p=0.514). The results were consistent in the PS-matched cohorts regarding major adverse cardiac events (HR 0.57, 95% CI [0.25, 1.29], p=0.176), overall mortality (HR 0.43, 95% CI [0.17, 1.11], p=0.820), and 30-day major hemorrhage events (OR 1.00, 95% CI [0.05, 10.61], p=0.999). Similar results were found in the subgroup analyses concerning fast-track management of 2-week intervals and patients with high age-adjusted Charlson comorbidity index. CONCLUSIONS: Under appropriate perioperative care, shortening the time interval between PCI and EVAR to 1 month, or even 2 weeks, seemed to be safe and effective. Short-term and midterm cardiovascular and survival outcomes were comparable with patients who underwent standard EVAR without significant coronary artery disease.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Weng C, Wang J, Zhao J, et al. Fast-Track Management of Concurrent Percutaneous Coronary Intervention in Patients Scheduled for Endovascular Abdominal Aortic Aneurysm Repair. J Endovasc Ther. 2022. PMID: 35786093. doi:10.1177/15266028221105179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。